EQUITY	6 Months Ended
Jun. 30, 2026
Equity [Abstract]
EQUITY	6. EQUITY Issuance of Common Stock On January 21, 2025, the Company entered into a securities purchase agreement for the issuance and sale of 3,333,333 shares of the Company’s common stock at a price of $0.15 per share. The aggregate proceeds to the Company were $500,000. On February 6, 2025, the Company entered into a securities purchase agreement for the issuance and sale of 555,556 shares of the Company’s common stock at a price of $0.18 per share. The aggregate proceeds to the Company were $100,000. On January 13, 2026, the Company entered into a securities purchase agreement for the issuance and sale of 1,033,333 shares of the Company’s common stock at a price of $0.15 per share. The aggregate proceeds to the Company were $155,000. On May 31, 2026, the Company entered into a securities purchase agreement for the issuance and sale of 6,256,704 shares of the Company’s common stock at a price of $0.28 per share. The aggregate proceeds to the Company were $1,750,000. On June 30, 2026, the Company entered into a securities purchase agreement for the issuance and sale of 1,887,584 shares of the Company’s common stock at a price of $0.40 per share. The aggregate proceeds to the Company were $750,000. Under the terms of a stock purchase agreement dated May 31, 2026, the Company has commitments to purchase shares of the Company’s common stock for an aggregate purchase price of $10,000,000, priced at the volume weighted average price for each applicable month. The Company has recorded $2,500,000 stock purchases under this agreement through June 30, 2026. Payment and issuance of future share purchases of $7,500,000 are scheduled to occur in installments of $750,000 per month through April 2027.

EQUITY

6 Months Ended

Jun. 30, 2026

6. EQUITY

Issuance of Common Stock

On January 21, 2025, the Company entered into a securities purchase agreement for the issuance and sale of 3,333,333 shares of the Company’s common stock at a price of $0.15 per share. The aggregate proceeds to the Company were $500,000.

On February 6, 2025, the Company entered into a securities purchase agreement for the issuance and sale of 555,556 shares of the Company’s common stock at a price of $0.18 per share. The aggregate proceeds to the Company were $100,000.

On January 13, 2026, the Company entered into a securities purchase agreement for the issuance and sale of 1,033,333 shares of the Company’s common stock at a price of $0.15 per share. The aggregate proceeds to the Company were $155,000.

On May 31, 2026, the Company entered into a securities purchase agreement for the issuance and sale of 6,256,704 shares of the Company’s common stock at a price of $0.28 per share. The aggregate proceeds to the Company were $1,750,000.

On June 30, 2026, the Company entered into a securities purchase agreement for the issuance and sale of 1,887,584 shares of the Company’s common stock at a price of $0.40 per share. The aggregate proceeds to the Company were $750,000.

Under the terms of a stock purchase agreement dated May 31, 2026, the Company has commitments to purchase shares of the Company’s common stock for an aggregate purchase price of $10,000,000, priced at the volume weighted average price for each applicable month. The Company has recorded $2,500,000 stock purchases under this agreement through June 30, 2026. Payment and issuance of future share purchases of $7,500,000 are scheduled to occur in installments of $750,000 per month through April 2027.